DMC Biotechnologies has executed an agreement with SCG Chemicals Co., Ltd to bring DMC’s L-Alanine and branched chain amino acids (BCAAs) into the ASEAN* markets. SCG was an investor in DMC’s Series A round in December 2019.
Matt Lipscomb, Ph.D., CEO & Co-Founder of DMC said, “The SCG agreement is another validation of our technology and our progress towards the commercialization of our first wave of products. We are excited to partner with SCG and leverage their wide reach to distribute our products into the ASEAN region.”
Mr. Suracha Udomsak, CTO and Emerging Business Director, Chemicals Business at SCG said, “SCG is a leader in sustainable development and is working hard to respond to the global climate emergency. DMC has a new route to making more sustainable and affordable L-Alanine and branched chain amino acids. We are excited by the opportunity to bring these biobased, sustainable solutions to the region and to contribute to a more sustainable society.”
*Association of Southeast Asian Nations (ASEAN): Brunei, Cambodia, Indonesia, Laos, Malaysia, Myanmar, Philippines, Singapore, Thailand and Vietnam.